| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.57 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.091 | 0.04 |